Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

This is from the February 24th 2019 News Release regarding Idiopathic Pulmonary Fibrosis (IPF):

A successful IPF in vivo study for NP-251 would mean that Algernon could begin planning an additional phase II study for its fourth major global disease”, said Christopher J. Moreau, CEO of Algernon Pharmaceuticals.” A potential new treatment for IPF could also mean an orphan drug designation, which could help expedite its availability to patients. We look forward to updating the market on our progress shortly.

My take is we will get an update regarding the IPF path to profits. However, since the above news release, we've gotten peppered with more. The most recent news releases were on April 1 and April 4, 2019. We can't expect to keep up the same pace leading up to launch of trials. At least I don't expect it. There's a lot of planning going on in the background to set up trials that simply will go unreported. How soon we get the next piece of news or what it entails is anybody's guess. All I know is there will be news of trials starting in 2019.

GL2ALL & T.G.I.F.

/////AMG